BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7524800)

  • 1. Emerging trends in antimicrobial resistance in surgical infections. A review.
    Neu HC
    Eur J Surg Suppl; 1994; (573):7-18. PubMed ID: 7524800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
    Aldridge KE
    Eur J Surg Suppl; 1994; (573):31-7. PubMed ID: 7524793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and mechanisms of bacterial resistance in surgical infections.
    Neu HC
    Am J Surg; 1995 May; 169(5A Suppl):13S-20S. PubMed ID: 7755162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors.
    Maddux MS
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):40S-50S. PubMed ID: 2041831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterococcis: pathogens of the 90s.
    Low DE; Willey BM; Betschel S; Kreiswirth B
    Eur J Surg Suppl; 1994; (573):19-24. PubMed ID: 7524791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic characteristics of coagulase-negative staphylococci: typing and antibiotic susceptibility.
    Jarløv JO
    APMIS Suppl; 1999; 91():1-42. PubMed ID: 10230367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
    Dudley M
    Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current challenges in antibiotic resistance.
    Hand WL
    Adolesc Med; 2000 Jun; 11(2):427-38. PubMed ID: 10916132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria.
    Obi CL; Makandiramba B; Robertson V; Tswana SA; Moyo SR; Nziramasanga P
    East Afr Med J; 1998 Mar; 75(3):162-5. PubMed ID: 9640815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriology of surgical wound infections in a tertiary care hospital in Turkey.
    Surucuoglu S; Gazi H; Kurutepe S; Ozkutuk N; Ozbakkaloglu B
    East Afr Med J; 2005 Jul; 82(7):331-6. PubMed ID: 16167704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing patterns of hospital infections: implications for therapy. Changing mechanisms of bacterial resistance.
    Neu HC
    Am J Med; 1984 Jul; 77(1B):11-23. PubMed ID: 6087659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extended-spectrum beta-lactamases: their role in clinical microbiology laboratory, treatment and infection control].
    Dolapçi I
    Mikrobiyol Bul; 2005 Apr; 39(2):229-40. PubMed ID: 16128036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral beta-lactamase inhibitor combinations for clinical use.
    Manzella JP
    Am Fam Physician; 1995 May; 51(7):1695-8. PubMed ID: 7754928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacterial resistance against beta-lactam antibiotics].
    Andersen BM
    Tidsskr Nor Laegeforen; 1990 Oct; 110(25):3233-9. PubMed ID: 2256036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.